Propylthiouracil-induced alveolar haemorrhage associated with antineutrophil cytoplasmic antibody

Propylthiouracil (PTU) is known to cause vasculitis as a rare complication. We report the case of a patient who developed alveolar haemorrhage and haematuria whilst treated with PTU. The serum was positive for antineutrophil cytoplasmic antibody (ANCA) with myeloperoxidase (MPO) specificity (MPO-ANCA). All symptoms resolved completely after discontinuation of PTU. Alveolar haemorrhage or pulmonary-renal syndrome associated with antineutrophil cytoplasmic antibody with myeloperoxidase specificity may be a new complication of propylthiouracil therapy.

This article has been cited by other articles:

				Y. Gao, M. Chen, H. Ye, F. Yu, X.-h. Guo, and M.-h. Zhao Long-term outcomes of patients with propylthiouracil-induced anti-neutrophil cytoplasmic auto-antibody-associated vasculitis Rheumatology, October 1, 2008; 47(10): 1515 - 1520. [Abstract] [Full Text] [PDF]

				Ph. Camus, P. Foucher, Ph. Bonniaud, and K. Ask Drug-induced infiltrative lung disease Eur. Respir. J., July 1, 2001; 18(32_suppl): 93S - 100s. [Abstract] [Full Text] [PDF]

				S. S. Dhillon, D. Singh, N. Doe, A. M. Qadri, S. Ricciardi, and M. I. Schwarz Diffuse Alveolar Hemorrhage and Pulmonary Capillaritis Due to Propylthiouracil Chest, November 1, 1999; 116(5): 1485 - 1488. [Abstract] [Full Text] [PDF]